(19)
(11) EP 1 931 374 A2

(12)

(43) Date of publication:
18.06.2008 Bulletin 2008/25

(21) Application number: 06749687.7

(22) Date of filing: 10.04.2006
(51) International Patent Classification (IPC): 
A61K 38/29(2006.01)
A61K 47/24(2006.01)
A61K 47/40(2006.01)
A61K 47/18(2006.01)
A61K 47/26(2006.01)
(86) International application number:
PCT/US2006/013377
(87) International publication number:
WO 2007/044069 (19.04.2007 Gazette 2007/16)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR MK YU

(30) Priority: 06.10.2005 US 246450
06.10.2005 US 246406
03.02.2006 US 347551
27.03.2006 US 390940

(71) Applicant: Nastech Pharmaceutical Company Inc.
Bothell, WA 98021-8906 (US)

(72) Inventors:
  • COSTANTINO, Henry, R.
    Woodinville, WA 98072 (US)
  • QUAY, Steven, C.
    Seattle, WA 98122 (US)
  • TEMPLIN, Michael, V.
    Bothell, WA 98122 (US)
  • LI, Ching-yuan
    Bellevue, WA 98006 (US)
  • SILENO, Anthony
    Brookhaven Hamlet, NY 11719 (US)

(74) Representative: Maggs, Michael Norman et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) PTH FORMULATIONS AND METHODS OF USE